Inhibin β-E inhibitors belong to a specific class of chemical compounds that have gained significance in the field of reproductive biology and endocrine regulation. Inhibin β-E, also known as Inhibin beta E subunit, is a subunit of the inhibin protein, which plays a crucial role in the endocrine system, particularly in the regulation of reproductive processes. Inhibin is a dimeric protein consisting of an α subunit and a β subunit. The β subunit can exist in several isoforms, and Inhibin β-E is one of these isoforms. Inhibin proteins are produced primarily by the gonads (testes in males and ovaries in females) and act as negative feedback regulators of the pituitary gland's secretion of follicle-stimulating hormone (FSH), thereby modulating gonadal function and hormone production. Inhibin β-E inhibitors are chemical compounds designed to interact with Inhibin β-E, potentially affecting its role in the regulation of FSH secretion and reproductive processes.
The mechanism of action of Inhibin β-E inhibitors typically involves their binding to Inhibin β-E subunit, often at specific binding sites or domains critical for its function. This interaction can lead to alterations in the inhibitory effect of Inhibin β-E on FSH secretion from the pituitary gland. Consequently, Inhibin β-E inhibitors may influence the delicate balance of hormonal regulation in the reproductive system, potentially impacting gonadal function and fertility. The study of Inhibin β-E inhibitors is essential in advancing our understanding of the intricate mechanisms governing endocrine regulation in reproduction, offering insights into how negative feedback mechanisms control hormone secretion and contribute to the overall physiology of the reproductive axis. Moreover, it contributes to the broader field of reproductive biology and endocrinology research, providing valuable tools for investigating the roles of Inhibin β-E and its isoforms in various physiological contexts related to reproduction.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY2109761 | 700874-71-1 | sc-396262 sc-396262A | 1 mg 5 mg | $87.00 $270.00 | 9 | |
A dual inhibitor of TGF-β receptor I and II, designed to impede TGF-β signaling, potentially altering the activity of INHBE. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $100.00 $408.00 | 6 | |
Though primarily known for its anti-fibrotic properties, it can modulate TGF-β activity, which might influence INHBE-related processes. | ||||||
SB 431542 | 301836-41-9 | sc-204265 sc-204265A sc-204265B | 1 mg 10 mg 25 mg | $80.00 $212.00 $408.00 | 48 | |
A selective inhibitor of ALK5, ALK4, and ALK7, impacting TGF-β signaling and possibly affecting INHBE function. | ||||||
A 83-01 | 909910-43-6 | sc-203791 sc-203791A | 10 mg 50 mg | $198.00 $650.00 | 16 | |
An inhibitor of ALK5, ALK4, and ALK7, it can disrupt TGF-β signaling, thereby potentially modulating INHBE activity. | ||||||
TGF-β RI Kinase Inhibitor V | 627536-09-8 | sc-203294 | 2 mg | $86.00 | 3 | |
A TGF-βR1 kinase inhibitor, it affects TGF-β signaling pathways which may have downstream effects on INHBE. | ||||||
EW-7197 | 1352608-82-2 | sc-507465 | 5 mg | $345.00 | ||
A selective inhibitor of TGF-β type I receptor kinase, potentially altering TGF-β mediated processes involving INHBE. | ||||||
LY2157299 | 700874-72-2 | sc-391123 sc-391123A | 5 mg 10 mg | $209.00 $352.00 | 3 | |
A selective inhibitor of TGF-β receptor I, which may indirectly impact INHBE through modulation of TGF-β signaling. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $30.00 $101.00 $277.00 $959.00 | 2 | |
Known to inhibit TGF-β release and expression, which could indirectly influence INHBE activities. | ||||||
ALK5 Inhibitor II | 446859-33-2 | sc-221234 sc-221234A sc-221234B sc-221234C sc-221234D sc-221234E sc-221234F | 1 mg 5 mg 10 mg 50 mg 100 mg 500 mg 1 g | $75.00 $150.00 $215.00 $650.00 $1224.00 $4296.00 $7818.00 | 8 | |
An inhibitor of ALK5, it can impede TGF-β signaling, potentially affecting INHBE-related processes. | ||||||
ITD 1 | 1099644-42-4 | sc-507349 | 10 mg | $220.00 | ||
A selective TGF-β pathway inhibitor, potentially modulating processes involving INHBE. | ||||||